Viewing StudyNCT04020016



Ignite Creation Date: 2024-05-06 @ 1:26 PM
Last Modification Date: 2024-10-26 @ 1:14 PM
Study NCT ID: NCT04020016
Status: UNKNOWN
Last Update Posted: 2020-10-06
First Post: 2019-05-30

Brief Title: Nalbuphine ER Effects of Liver Disease on Pharmacokinetics and Itch
Sponsor: Trevi Therapeutics
Organization: Trevi Therapeutics

Conditions & Keywords Data

Conditions:
Name
Hepatic Impairment
Nalbuphine
Keywords:
Name View
nalbuphine View
Pharmacokinetic View
hepatic impairment View